LIFEBRIDGE Medizintechnik : New ACCF/AHA/SCAI Guidelines with increased recommendations for the use of extracorporeal hemodynamic support in patients with cardiac or cardio-pulmonary failure.

January 17, 2012 - LIFEBRIDGE Medizintechnik AG announces increased recommendations for hemodynamic support by guidelines for percutaneous coronary interventions (PCI). Issued by the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and the Society for Coronary Angiography and Interventions (SCAI), guidelines provide expanded recommendations for hemodynamic support in patients with cardiogenic shock, during high-risk PCIs and to stabilize emergent patients in hospitals without on-site cardiac surgery. The portable LIFEBRIDGEâ system, with its clinically proven capability to completely substitute cardiac function and oxygenate emergency patients, is the ideal cardiopulmonary support system for PCI centers to fulfill the updated guideline recommendations... LIFEBRIDGE Medizintechnik's Press Release -

Cellartis : partner in CardioNet, an EU-project with the aim to develop novel therapeutic tools for identification of heart disease

JANUARY 23, 2012 - Cellartis is a partner in CardioNet, an EU-project with the aim to develop novel therapeutic tools for identification of heart disease -

Enabling functional recovery of the heart after myocardial infarction through cardiac regeneration and repair is a major goal of cardiovascular and regenerative medicine. The CardioNet network, coordinated by the Spanish National Centre for Cardiovascular Research (CNIC), aims at integrating knowledge from holistic molecular and cellular biology approaches in order to better understand the regulation of heart development, homeostasis, and disease. This knowledge will contribute to the identification of new targets and the development of novel therapeutic tools for heart disease. In order to achieve these aims, a diverse interdisciplinary set of partners has been assembled comprising 13 partners throughout Europe.

About Cellectis stem cells :  Cellectis stem cells speeds up the development of stem cell technology in particular to find a robust and reproducible way of controlling stem cell production and differentiation. Through the sharing of knowledge and expertise developed by the the two companies forming Cellectis stem cells - Cellartis and Ectycell – Cellectis stem cells becomes a major, long-term and stable industrial player in the global marketplace... Cellartis' Press Release -